🔎 Trials Near Me

Utama › Fibrosis Kistik › Alabama

Kajian klinikal Fibrosis Kistik di Alabama

16 kajian untuk Fibrosis Kistik sedang mencari peserta di lokasi di Alabama.

Bandar di Alabama

Teks kajian rasmi (Bahasa Inggeris)

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

  • The Children's Hospital Alabama & University of Alabama at Birmingham, Birmingham
Mengambil peserta
Umur 3 hingga 18 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06654752

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

  • The Children's Hospital Alabama, University of Alabama at Birmingham, Birmingham
Mengambil pesertaKajian pemerhatian
Sehingga umur 10 · Semua jantina · Dikemas kini 8 Jul 2026 · NCT04509050

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

  • The Children's Hospital Alabama, University of Alabama at Birmingham, Birmingham
Mengambil pesertaFasa 4
Umur 6 ke atas · Semua jantina · Dikemas kini 8 Jul 2026 · NCT05548283

4D-710 in Adult Patients With Cystic Fibrosis

  • University of Alabama Child Health Research Unit, Birmingham
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Jul 2026 · NCT05248230

Ensuring Access to Optimal Therapy in CF: The ENACT Study

  • The University of Alabama at Birmingham, Birmingham
Mengambil pesertaFasa 4
Umur 3 ke atas · Semua jantina · Dikemas kini 2 Jun 2026 · NCT07148739

Rare CFTR Mutation Cell Collection Protocol (RARE)

  • University of Alabama at Birmingham, Birmingham
Mengambil pesertaKajian pemerhatianMenyebut bayaran untuk peserta
Umur 17 ke atas · Semua jantina · Dikemas kini 29 Mei 2026 · NCT03161808

Role of Body Fat Distribution in Metabolic and Pulmonary Decline in Cystic Fibrosis (ORBIT-CF)

  • University of Alabama at Birmingham (UAB)/Children's of Alabama, Birmingham
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 16 ke atas · Semua jantina · Dikemas kini 18 Mei 2026 · NCT04002882

Kidney Function in People With Cystic Fibrosis in the Era of HEMT

  • University of Alabama at Birmingham, Birmingham
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 7 ke atas · Semua jantina · Dikemas kini 4 Mei 2026 · NCT06595420

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

  • University of Alabama at Birmingham, Birmingham
Mengambil pesertaKajian pemerhatian
Umur 12 ke atas · Semua jantina · Dikemas kini 10 Feb 2026 · NCT06837181

Personalized Theratyping Trial

  • University of Alabama at Birmingham, Birmingham
Mengambil pesertaFasa awal 1
Umur 6 ke atas · Semua jantina · Dikemas kini 2 Feb 2026 · NCT03587961

OnTrackCF: Engagement, Feasibility, and Acceptability Study

  • University of Alabama-Birmingham, Birmingham
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Dis 2025 · NCT07031323

Health Outcomes of Parents With Cystic Fibrosis-Aim 2

  • University of Alabama-Birmingham, Birmingham
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Nov 2025 · NCT06296394

Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

  • University of Alabama at Birmingham, Birmingham
Mengambil pesertaKajian pemerhatian
Umur 6 ke atas · Semua jantina · Dikemas kini 3 Nov 2025 · NCT06683092

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

  • The Children's Hospital Alabama, University of Alabama at Birmingham, Birmingham
Mengambil pesertaKajian pemerhatian
Umur 12 ke atas · Semua jantina · Dikemas kini 1 Okt 2025 · NCT06504589

IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)

  • University of Alabama at Birmingham, Birmingham
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2025 · NCT04294043

Study With Phage for CF Subjects With Pseudomonas Lung Infection

  • University of Alabama at Birmingham, Birmingham
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jul 2025 · NCT06998043

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.